- Home
- CLPT vs MTLS Comparison
CLPT vs MTLS Comparison
Compare CLPT & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLPT | MTLS |
|---|---|---|
| Founded | 1998 | 1990 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.9M | 431.6M |
| IPO Year | 2009 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CLPT | MTLS |
|---|---|---|
| Price | $9.11 | $8.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $23.50 | $8.76 |
| AVG Volume (30 Days) | ★ 649.3K | 225.3K |
| Earning Date | 10-28-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,971,000.00 | N/A |
| Revenue This Year | $32.54 | $3.97 |
| Revenue Next Year | $15.41 | $5.95 |
| P/E Ratio | ★ N/A | $61.39 |
| Revenue Growth | ★ 17.78 | N/A |
| 52 Week Low | $8.27 | $4.78 |
| 52 Week High | $27.27 | $8.82 |
Technical Indicators
Market Signals| Indicator | CLPT | MTLS |
|---|---|---|
| Relative Strength Index (RSI) | 31.63 | 66.85 |
| Support Level | $8.61 | $6.37 |
| Resistance Level | $15.30 | $8.82 |
| Average True Range (ATR) | 0.48 | 0.22 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 5.20 | 96.75 |
Price Performance
Historical ComparisonAbout CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
About MTLS Materialise NV
Materialise NV is a provider of 3D-printed medical devices and software and a pioneer in additive manufacturing software and services. The company operates through three principal segments: Materialise Software, Materialise Medical, and Materialise Manufacturing, with the Materialise Medical segment generating maximum revenue. The Materialise Medical segment develops and delivers medical software solutions, medical devices, and related products and services; the Materialise Software segment develops and delivers additive manufacturing software solutions and related services; and the Materialise Manufacturing segment delivers 3D-printed products and related services. The company generates maximum revenue from the United States of America.